THE LATEST FROM MiRus

MoRe® News

Press Releases

July 31, 2024

MiRus Receives Breakthrough Device Designation for Spine Implant

Atlanta – July 31, 2024 – MiRus has received Breakthrough Device Designation from the FDA for the EUROPA® Posterior Cervical System, based on it’s proprietary rhenium alloys, for treatment of the cervical and upper thoracic spine.  The EUROPA® PCF system is built around a 2.9 mm MoRe rod which is much smaller than current commercial …

MiRus Receives Breakthrough Device Designation for Spine Implant Read More »

Read More →
June 6, 2024

MiRus Siegel™ TAVR: First in Human Results Presented at New York Valves

New York – June 6, 2024 – Pradeep K. Yadav MD, Director of Structural Interventions, Piedmont Heart Institute, Atlanta presented the initial experience with the MiRus Siegel™ 8-Fr aortic transcatheter heart valve (THV) at the New York Valves conference. Five sequential patients with severe, symptomatic aortic stenosis (AS) were treated at the Instituto Nacional Del …

MiRus Siegel™ TAVR: First in Human Results Presented at New York Valves Read More »

Read More →
October 18, 2023

MiRus® Announces FDA 510(k) Clearance for Molybdenum-Rhenium (MoRe®) Low Profile Anterior Cervical and Lateral Lumbar Plating Systems

ATLANTA — October 18, 2023 — MiRus® announced that it has received FDA 510(k) clearance of the CYGNUS™ MoRe® Anterior Cervical Plate and MiRus® 3DR™ Lateral Lumbar Interbody Fusion System with Integrated MoRe® plate fixation, both being the narrowest and thinnest plating system amongst all plates on the global spine market. MoRe®, a proprietary molybdenum …

MiRus® Announces FDA 510(k) Clearance for Molybdenum-Rhenium (MoRe®) Low Profile Anterior Cervical and Lateral Lumbar Plating Systems Read More »

Read More →
September 18, 2023

MiRus® Announces Launch of Molybdenum-Rhenium Low Profile ATLAS™ MoRe® Foot and Ankle Plating System

ATLANTA — September  18, 2023— MiRus announces limited market release in the U.S. of its  ATLAS™ MoRe® Foot and Ankle Plating System, the thinnest  foot and ankle plate on the market for treatment of foot and ankle conditions. The molybdenum-rhenium alloy used in the plates allows for a dramatically smaller footprint of 1.0mm thickness without …

MiRus® Announces Launch of Molybdenum-Rhenium Low Profile ATLAS™ MoRe® Foot and Ankle Plating System Read More »

Read More →
December 2, 2021

MiRus® Announces Plans for Site of New Headquarters

MiRus announces plans for site of new headquarters with the purchase of the Franklin Gateway 6.72 acre property from the City of Marietta. The new headquarters will be a three-story facility comprising over 70,000 square feet. https://www.mariettaga.gov/CivicAlerts.aspx?AID=3474
Read More →
August 31, 2021

MiRus® Receives FDA 510(K) Clearance For
The Lowest Profile and Best-in-class Expandable Lumbar Interbody

ATLANTA- August 31, 2021 – MiRus LLC, the leading innovator in rhenium-based superalloy medical implants announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its IO™ Expandable Lumbar Interbody. The IO™ Expandable Lumbar Interbody can be utilized in both PLIF and TLIF procedures.  It features the lowest insertion profile …

MiRus® Receives FDA 510(K) Clearance For
The Lowest Profile and Best-in-class Expandable Lumbar Interbody Read More »

Read More →
July 27, 2021

MiRus® Raises $65 Million For Expansion of Rhenium-based Medical Devices

ATLANTA- July 27, 2021 – MiRus LLC, a commercial stage life sciences company, has completed a highly oversubscribed funding round for growth of its spine and extremity portfolios and development of structural heart disease solutions using its proprietary Rhenium-based alloys (MoRe®).  The round was led by Mammoth Scientific and multi-generational family offices who have supported …

MiRus® Raises $65 Million For Expansion of Rhenium-based Medical Devices Read More »

Read More →
February 23, 2021

MiRus® Launches MoRe® Promise- a Lifetime Limited Warranty for its Molybdenum-Rhenium Superalloy Rod.

MiRus announced today that they will offer a LIFETIME LIMITED WARRANTY on its Molybdenum-Rhenium ( MoRe®) superalloy rod technology. The warranty will cover full replacement of the MoRe® Rod and corresponding MiRus hardware used in spinal fusion cases should the MoRe® Rod fracture. The warranty will cover all thoracolumbar MoRe® rods implanted as part of the EUROPA™ Pedicle Screw System supplied by MiRus in the United States effective March 1, 2021.
Read More →
June 11, 2020

MiRus® Announces First Clinical Use of the MiRus® 3DR™ Printed Lumbar Interbody Fusion System.

MiRus is pleased to announce that it received FDA 510(k) clearance for its 3DR™ (Randomized) Printed Lumbar Interbody Fusion System which consists of the CALLISTO 3DR™ PLIF, HYPERION 3DR™ TLIF, CALYPSO 3DR™ LLIF and the ANTARES 3DR™ ALIF.
Read More →
August 30, 2019

First Spine Surgeries using the MoRe® Superalloy.

MiRus announces successful spine surgeries at several centers across the country using the MoRe® superalloy. MiRus had received FDA 510(k) clearance for the MoRe® based Europa™ Pedicle Screw System earlier this year.
Read More →

Dr. Yadav - Inventing A Healthier Future

Play Video

The Latest from MiRus

MiRus Receives Breakthrough Device Designation for Spine Implant

July 31, 2024

MiRus Siegel™ TAVR: First in Human Results Presented at New York Valves

June 6, 2024

MiRus® Announces FDA 510(k) Clearance for Molybdenum-Rhenium (MoRe®) Low Profile Anterior Cervical and Lateral Lumbar Plating Systems

October 18, 2023

MiRus® receives the 2023 Spine Tech Award for its Low-profile Molybdenum-Rhenium (MoRe®) Lumbar Plating Systems

October 13, 2023